a public good project by the
Synthesis
Company
of California

© 2026

Naoe Goto | doi.page

0 works0 citations0 h-index

Naoe Goto

Fujita Health University(JP)Pharmaceuticals and Medical Devices Agency(JP)

Publications by Year

Research Areas

Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Tryptophan and brain disorders, Viral-associated cancers and disorders, CNS Lymphoma Diagnosis and Treatment

Most-Cited Works

→ Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy for Diagnosis of Lymphoproliferative Disorders: Feasibility of Immunohistological, Flow Cytometric, and Cytogenetic Assessments(2011)103 cited
→ Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma(2015)98 cited
→ Clinicopathologic analysis of IgG4-related skin disease(2012)88 cited
→ Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP(2010)86 cited
→ Serum concentration of L‐kynurenine predicts the clinical outcome of patients with diffuse large B‐cell lymphoma treated with R‐CHOP(2009)70 cited
→ Duodenal follicular lymphoma: Comprehensive gene expression analysis with insights into pathogenesis(2014)68 cited

→ Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens(2011)

63 cited

→ Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin?s lymphoma: in combination with the International Prognostic Index(2004)63 cited

→ Intrahepatic cholangiocarcinoma arising 10 years after the excision of congenital extrahepatic biliary dilation(2001)61 cited

→ A phase II study of a THP‐COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B‐cell lymphoma(2007)48 cited